Long-term impact of alcohol on the brain

Last updated

The long-term impact of alcohol on the brain has become a growing area of research focus. While researchers have found that moderate alcohol consumption in older adults is associated with better cognition and well-being than abstinence, [1] excessive alcohol consumption is associated with widespread and significant brain lesions. Other data – including investigated brain-scans of 36,678 UK Biobank participants – suggest that even "light" or "moderate" consumption of alcohol by itself harms the brain, such as by reducing brain grey matter volume. This may imply that alternatives and generally aiming for lowest possible consumption could usually be the advisable approach.

Contents

Despite these physiological effects in principle, in some cases occasional moderate consumption may have ancillary benefits on the brain due to social and psychological benefits if compared to alcohol abstinence and soberness. [2]

While the extent of causation is difficult to prove, alcohol intake – even at levels often considered to be low – "is negatively associated with global brain volume measures, regional gray matter volumes, and white matter microstructure" and these associations become stronger as alcohol intake increases. [3] [4] [5] [6]

The effects can manifest much later—mid-life Alcohol Use Disorder has been found to correlate with increased risk of severe cognitive and memory deficits in later life. [7] [8] Alcohol related brain damage is not only due to the direct toxic effects of alcohol; alcohol withdrawal, nutritional deficiency, electrolyte disturbances, and liver damage are also believed to contribute to alcohol-related brain damage. [9]

Adolescent brain development

Consuming large amounts of alcohol over a period of time can impair normal brain development in humans. [10] [ vague ] Deficits in retrieval of verbal and nonverbal information and in visuospatial functioning were evident in youths with histories of heavy drinking during early and middle adolescence. [11] [12]

During adolescence critical stages of neurodevelopment occur, including remodeling and functional changes in synaptic plasticity and neuronal connectivity in different brain regions. These changes may make adolescents especially susceptible to the harmful effects of alcohol. Compared to adults, adolescents exposed to alcohol are more likely to exhibit cognitive deficits (including learning and memory dysfunction). Some of these cognitive effects, such as learning impairments, may persist into adulthood. [13]

Mechanisms of action

Neuroinflammation

Ethanol can trigger the activation of astroglial cells which can produce a proinflammatory response in the brain. Ethanol interacts with the TLR4 and IL-1RI receptors on these cells to activate intracellular signal transduction pathways. Specifically, ethanol induces the phosphorylation of IL-1R-associated kinase (IRAK), ERK1/2, stress-activated protein kinase (SAPK)/JNK, and p38 mitogen-activated protein kinase (p38 MAPK). Activation of the IRAK/MAPK pathway leads to the stimulation of the transcription factors NF-kappaB and AP-1. These transcription factors cause the upregulation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression. [14] The upregulation of these inflammatory mediators by ethanol is also associated with an increase in caspase 3 activity and a corresponding increase in cell apoptosis. [14] [15] The exact mechanism by which various concentrations of ethanol either activates or inhibits TLR4/IL-1RI signaling is not currently known, though it may involve alterations in lipid raft clustering [16] or cell adhesion complexes and actin cytoskeleton organization. [17]

Changes in dopaminergic and glutamatergic signaling pathways

Intermittent ethanol treatment causes a decrease in expression of the dopamine receptor type 2 (D2R) and a decrease in phosphorylation of 2B subunit of the NMDA receptor (NMDAR2B) in the prefrontal cortex, hippocampus, nucleus accumbens, and for only D2R the striatum. It also causes changes in the acetylation of histones H3 and H4 in the prefrontal cortex, nucleus accumbens, and striatum, suggesting chromatin remodeling changes which may mediate long-term alterations. Additionally, adolescent rats pre-exposed to ethanol have higher basal levels of dopamine in the nucleus accumbens, along with a prolonged dopamine response in this area in response to a challenge dose of ethanol. Together, these results suggest that alcohol exposure during adolescence can sensitize the mesolimbic and mesocortical dopamine pathways to cause changes in dopaminergic and glutamatergic signaling, which may affect the remodeling and functions of the adolescent brain. [18] These changes are significant as alcohol’s effect on NMDARs could contribute to learning and memory dysfunction (see Effects of alcohol on memory ).

Inhibition of hippocampal neurogenesis

Excessive alcohol intake (binge drinking) causes a decrease in hippocampal neurogenesis, via decreases in neural stem cell proliferation and newborn cell survival. [19] [20] Alcohol decreases the number of cells in S-phase of the cell cycle, and may arrest cells in the G1 phase, thus inhibiting their proliferation. [19] Ethanol has different effects on different types of actively dividing hippocampal progenitors during their initial phases of neuronal development. Chronic alcohol exposure decreases the number of proliferating cells that are radial glia-like, preneuronal, and intermediate types, while not affecting early neuronal type cells; suggesting ethanol treatment alters the precursor cell pool. Furthermore, there is a greater decrease in differentiation and immature neurons than there is in proliferating progenitors, suggesting that the abnormal decrease in the percentage of actively dividing preneuronal progenitors results in a greater reduction in the maturation and survival of postmitotic cells. [20]

Additionally, alcohol exposure increased several markers of cell death. In these studies neural degeneration seems to be mediated by non-apoptotic pathways. [19] [20] One of the proposed mechanisms for alcohol’s neurotoxicity is the production of nitric oxide (NO), yet other studies have found alcohol-induced NO production to lead to apoptosis (see Neuroinflammation section).

Transient versus stable alterations

Many negative physiologic consequences of alcoholism are reversible during abstinence. As an example, long-term chronic alcoholics suffer a variety of cognitive deficiencies. [21] However, multiyear abstinence resolves most neurocognitive deficits, except for some lingering deficits in spatial processing. [22] Nevertheless there are some frequent long-term consequences that are not reversible during abstinence. Alcohol craving (compulsive need to consume alcohol) is frequently present long-term among alcoholics. [23] Among 461 individuals who sought help for alcohol problems, followup was provided for up to 16 years. [24] By 16 years, 54% of those who tried to remain abstinent without professional help had relapsed, and 39% of those who tried to remain abstinent with help had relapsed.

Alcohol consumption can substantially impair neurobiologically-beneficial and -demanding exercise. [25]

Long-term, stable consequences of chronic hazardous alcohol use are thought to be due to stable alterations of gene expression resulting from epigenetic changes within particular regions of the brain. [26] [27] [28] For example, in rats exposed to alcohol for up to 5 days, there was an increase in histone 3 lysine 9 acetylation in the pronociceptin promoter in the brain amygdala complex. This acetylation is an activating mark for pronociceptin. The nociceptin/nociceptin opioid receptor system is involved in the reinforcing or conditioning effects of alcohol. [29]

Results of alcohol consumption levels Results of study "No safe level of alcohol consumption for brain health - observational cohort study of 25 378 UK Biobank participants".png
Results of alcohol consumption levels

Related Research Articles

<span class="mw-page-title-main">Alcohol abuse</span> Substance abuse of alcoholic beverages

Alcohol abuse encompasses a spectrum of alcohol-related substance abuse, ranging from the consumption of more than 2 drinks per day on average for men, or more than 1 drink per day on average for women, to binge drinking or alcohol use disorder.

<span class="mw-page-title-main">Neurotoxin</span> Toxin harmful to nervous tissue

Neurotoxins are toxins that are destructive to nerve tissue. Neurotoxins are an extensive class of exogenous chemical neurological insults that can adversely affect function in both developing and mature nervous tissue. The term can also be used to classify endogenous compounds, which, when abnormally contacted, can prove neurologically toxic. Though neurotoxins are often neurologically destructive, their ability to specifically target neural components is important in the study of nervous systems. Common examples of neurotoxins include lead, ethanol, glutamate, nitric oxide, botulinum toxin, tetanus toxin, and tetrodotoxin. Some substances such as nitric oxide and glutamate are in fact essential for proper function of the body and only exert neurotoxic effects at excessive concentrations.

The long-term effects of alcohol have been extensively researched. The health effects of long-term alcohol consumption on health vary depending on the amount consumed. Even light drinking poses health risks, but atypically small amounts of alcohol may have health benefits. Alcoholism causes severe health consequences which outweigh any potential benefits.

Neuropharmacology is the study of how drugs affect function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. Behavioral neuropharmacology focuses on the study of how drugs affect human behavior (neuropsychopharmacology), including the study of how drug dependence and addiction affect the human brain. Molecular neuropharmacology involves the study of neurons and their neurochemical interactions, with the overall goal of developing drugs that have beneficial effects on neurological function. Both of these fields are closely connected, since both are concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Studying these interactions, researchers are developing drugs to treat many different neurological disorders, including pain, neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, psychological disorders, addiction, and many others.

Alcohol has a number of effects on health. Short-term effects of alcohol consumption include intoxication and dehydration. Long-term effects of alcohol include changes in the metabolism of the liver and brain, with increased risk of several types of cancer and alcohol use disorder. Alcohol intoxication affects the brain, causing slurred speech, clumsiness, and delayed reflexes. There is an increased risk of developing an alcohol use disorder for teenagers while their brain is still developing. Adolescents who drink have a higher probability of injury including death.

<span class="mw-page-title-main">Acamprosate</span> Medication

Acamprosate, sold under the brand name Campral, is a medication which reduces alcoholism cravings. It is thought to stabilize chemical signaling in the brain that would otherwise be disrupted by alcohol withdrawal. When used alone, acamprosate is not an effective therapy for alcohol use disorder in most individuals, as it only addresses withdrawal symptoms and not psychological dependence. It facilitates a reduction in alcohol consumption as well as full abstinence when used in combination with psychosocial support or other drugs that address the addictive behavior.

Neuroimmunology is a field combining neuroscience, the study of the nervous system, and immunology, the study of the immune system. Neuroimmunologists seek to better understand the interactions of these two complex systems during development, homeostasis, and response to injuries. A long-term goal of this rapidly developing research area is to further develop our understanding of the pathology of certain neurological diseases, some of which have no clear etiology. In doing so, neuroimmunology contributes to development of new pharmacological treatments for several neurological conditions. Many types of interactions involve both the nervous and immune systems including the physiological functioning of the two systems in health and disease, malfunction of either and or both systems that leads to disorders, and the physical, chemical, and environmental stressors that affect the two systems on a daily basis.

A drug-related blackout is a phenomenon caused by the intake of any substance or medication in which short-term and long-term memory creation is impaired, therefore causing a complete inability to recall the past. Blackouts are frequently described as having effects similar to that of anterograde amnesia, in which the subject cannot recall any events after the event that caused amnesia.

Post-acute withdrawal syndrome (PAWS) is a hypothesized set of persistent impairments that occur after withdrawal from alcohol, opiates, benzodiazepines, antidepressants, and other substances. Infants born to mothers who used substances of dependence during pregnancy may also experience a PAWS. While PAWS has been frequently reported by those withdrawing from opiate and alcohol dependence, the research has limitations. Protracted benzodiazepine withdrawal has been observed to occur in some individuals prescribed benzodiazepines.

<span class="mw-page-title-main">Short-term effects of alcohol consumption</span> Overview of the short-term effects of the consumption of alcoholic beverages

The short-term effects of alcohol consumption range from a decrease in anxiety and motor skills and euphoria at lower doses to intoxication (drunkenness), to stupor, unconsciousness, anterograde amnesia, and central nervous system depression at higher doses. Cell membranes are highly permeable to alcohol, so once it is in the bloodstream, it can diffuse into nearly every cell in the body.

<span class="mw-page-title-main">Binge drinking</span> Form of excessive alcohol intake

Binge drinking, or heavy episodic drinking, is drinking alcoholic beverages with an intention of becoming intoxicated by heavy consumption of alcohol over a short period of time, but definitions vary considerably.

<span class="mw-page-title-main">Effects of alcohol on memory</span> Health effect of alcohol consumption

Effects of alcohol on memory include disruption of various memory processes, affecting both formation and recall of information.

Kindling due to substance withdrawal is the neurological condition which results from repeated withdrawal episodes from sedative–hypnotic drugs such as alcohol and benzodiazepines.

Behavioral epigenetics is the field of study examining the role of epigenetics in shaping animal and human behavior. It seeks to explain how nurture shapes nature, where nature refers to biological heredity and nurture refers to virtually everything that occurs during the life-span. Behavioral epigenetics attempts to provide a framework for understanding how the expression of genes is influenced by experiences and the environment to produce individual differences in behaviour, cognition, personality, and mental health.

Addiction vulnerability is an individual's risk of developing an addiction during their lifetime. There are a range of genetic and environmental risk factors for developing an addiction that vary across the population. Genetic and environmental risk factors each account for roughly half of an individual's risk for developing an addiction; the contribution from epigenetic risk factors to the total risk is unknown. Even in individuals with a relatively low genetic risk, exposure to sufficiently high doses of an addictive drug for a long period of time can result in an addiction. In other words, anyone can become an individual with a substance use disorder under particular circumstances. Research is working toward establishing a comprehensive picture of the neurobiology of addiction vulnerability, including all factors at work in propensity for addiction.

<span class="mw-page-title-main">Alcohol (drug)</span> Active ingredient in alcoholic beverages

Alcohol, sometimes referred to by the chemical name ethanol, is a depressant drug that is the active ingredient in drinks such as beer, wine, and distilled spirits. It is one of the oldest and most commonly consumed recreational drugs, causing the characteristic effects of alcohol intoxication ("drunkenness"). Among other effects, alcohol produces happiness and euphoria, decreased anxiety, increased sociability, sedation, impairment of cognitive, memory, motor, and sensory function, and generalized depression of central nervous system (CNS) function. Ethanol is only one of several types of alcohol, but it is the only type of alcohol that is found in alcoholic beverages or commonly used for recreational purposes; other alcohols such as methanol and isopropyl alcohol are significantly more toxic. A mild, brief exposure to isopropyl alcohol is unlikely to cause any serious harm, but methanol is lethal even in small quantities, as little as 10–15 milliliters.

Alcohol-related brain damage alters both the structure and function of the brain as a result of the direct neurotoxic effects of alcohol intoxication or acute alcohol withdrawal. Increased alcohol intake is associated with damage to brain regions including the frontal lobe, limbic system, and cerebellum, with widespread cerebral atrophy, or brain shrinkage caused by neuron degeneration. This damage can be seen on neuroimaging scans.

Caffeine-induced anxiety disorder is a subclass of the DSM-5 diagnosis of substance/medication-induced anxiety disorder.

Alcoholism is a chronic disease characterized by trouble controlling the consumption of alcohol, dependence, and withdrawal upon rapid cessation of drinking. According to ARDI reports approximately 88,000 people had alcohol-related deaths in the United States between the years of 2006 and 2010. Furthermore, chronic alcohol use is consistently the third leading cause of death in the United States. In consequence, research has sought to determine the factors responsible for the development and persistence of alcoholism. From this research, several molecular and epigenetic mechanisms have been discovered.

Epigenetics of anxiety and stress–related disorders is the field studying the relationship between epigenetic modifications of genes and anxiety and stress-related disorders, including mental health disorders such as generalized anxiety disorder (GAD), post-traumatic stress disorder, obsessive-compulsive disorder (OCD), and more. These changes can lead to transgenerational stress inheritance.

References

  1. ↑ Lang I, Wallace RB, Huppert FA, Melzer D (2007). "Moderate alcohol consumption in older adults is associated with better cognition and well-being than abstinence". Age and Ageing. 36 (3): 256–61. doi: 10.1093/ageing/afm001 . PMID   17353234. Open Access logo PLoS transparent.svg
  2. ↑ Dunbar RI, Launay J, Wlodarski R, Robertson C, Pearce E, Carney J, MacCarron P (1 June 2017). "Functional Benefits of (Modest) Alcohol Consumption". Adaptive Human Behavior and Physiology. 3 (2): 118–133. doi:10.1007/s40750-016-0058-4. ISSN   2198-7335. PMC   7010365 . PMID   32104646.
  3. ↑ Ramirez E. "Study: No Amount Of Drinking Alcohol Is Safe For Brain Health". Forbes. Retrieved 13 June 2021.
  4. 1 2 Topiwala A, Ebmeier KP, Maullin-Sapey T, Nichols TE (2021-05-12). "No safe level of alcohol consumption for brain health: observational cohort study of 25,378 UK Biobank participants". medRxiv   10.1101/2021.05.10.21256931v1 . CC-BY icon.svg Available under CC BY 4.0.
  5. ↑ "Sorry, wine lovers. No amount of alcohol is good for you, study says". Washington Post. Retrieved 19 April 2022.
  6. ↑ Daviet R, Aydogan G, Jagannathan K, Spilka N, Koellinger PD, Kranzler HR, Nave G, Wetherill RR (4 March 2022). "Associations between alcohol consumption and gray and white matter volumes in the UK Biobank". Nature Communications. 13 (1): 1175. Bibcode:2022NatCo..13.1175D. doi:10.1038/s41467-022-28735-5. ISSN   2041-1723. PMC   8897479 . PMID   35246521.
  7. ↑ Caroline Cassels (July 30, 2014). "Midlife Alcohol Abuse Linked to Severe Memory Impairment". Medscape. WebMD LLC.
  8. ↑ Kuźma EB, Llewellyn DJ, Langa KM, Wallace RB, Lang IA (2014). "History of Alcohol Use Disorders and Risk of Severe Cognitive Impairment: A 19-Year Prospective Cohort Study". The American Journal of Geriatric Psychiatry. 22 (10): 1047–1054. doi: 10.1016/j.jagp.2014.06.001 . PMC   4165640 . PMID   25091517.
  9. ↑ Neiman J (Oct 1998). "Alcohol as a risk factor for brain damage: neurologic aspects". Alcohol. Clin. Exp. Res. 22 (7 Suppl): 346S–351S. doi:10.1111/j.1530-0277.1998.tb04389.x. PMID   9799959.
  10. ↑ Tapert SF, Brown GG, Kindermann SS, Cheung EH, Frank LR, Brown SA (February 2001). "fMRI measurement of brain dysfunction in alcohol-dependent young women". Alcohol. Clin. Exp. Res. 25 (2): 236–45. doi:10.1111/j.1530-0277.2001.tb02204.x. PMID   11236838.
  11. ↑ Squeglia LM, Jacobus J, Tapert SF (January 2009). "The influence of substance use on adolescent brain development". Clin EEG Neurosci. 40 (1): 31–8. doi:10.1177/155005940904000110. PMC   2827693 . PMID   19278130.
  12. ↑ Brown SA, Tapert SF, Granholm E, Delis DC (February 2000). "Neurocognitive functioning of adolescents: effects of protracted alcohol use". Alcohol. Clin. Exp. Res. 24 (2): 164–71. doi:10.1111/j.1530-0277.2000.tb04586.x. PMID   10698367.
  13. ↑ Guerri C, Pascual MA (2010). "Mechanisms involved in the neurotoxic, cognitive, and neurobehavioral effects of alcohol consumption during adolescence". Alcohol. 44 (1): 15–26. doi:10.1016/j.alcohol.2009.10.003. PMID   20113871.
  14. 1 2 Blanco Am VS, Vallés SL, Pascual M, Guerri C (2005). "Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes". Journal of Immunology. 175 (10): 6893–6899. doi: 10.4049/jimmunol.175.10.6893 . PMID   16272348.
  15. ↑ Pascual M, Blanco AM, Cauli O, Miñarro J, Guerri C (2007). "Intermittent ethanol exposure induces inflammatory brain damage and causes long-term behavioural alterations in adolescent rats". European Journal of Neuroscience. 25 (2): 541–550. doi:10.1111/j.1460-9568.2006.05298.x. PMID   17284196. S2CID   26318057.
  16. ↑ Fernandez-Lizarbe S, Pascual M, Gascon MS, Blanco A, Guerri C (2008). "Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages". Molecular Immunology. 45 (7): 2007–2016. doi:10.1016/j.molimm.2007.10.025. PMID   18061674.
  17. ↑ Guasch RM, Tomas M, Miñambres R, Valles S, Renau-Piqueras J, Guerri C (2003). "RhoA and lysophosphatidic acid are involved in the actin cytoskeleton reorganization of astrocytes exposed to ethanol". Journal of Neuroscience Research. 72 (4): 487–502. doi:10.1002/jnr.10594. hdl: 10550/95175 . PMID   12704810. S2CID   22182633.
  18. ↑ Pascual M, Boix J, Felipo V, Guerri C (2009). "Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat". Journal of Neurochemistry. 108 (4): 920–931. doi: 10.1111/j.1471-4159.2008.05835.x . PMID   19077056.
  19. 1 2 3 Morris SA, Eaves DW, Smith AR, Nixon K (2009). "Alcohol inhibition of neurogenesis: A mechanism of hippocampal neurodegeneration in an adolescent alcohol abuse model". Hippocampus. 20 (5): 596–607. doi:10.1002/hipo.20665. PMC   2861155 . PMID   19554644.
  20. 1 2 3 Taffe MA, Kotzebue RW, Crean RD, Crawford EF, Edwards S, Mandyam CD (2010). "Long-lasting reduction in hippocampal neurogenesis by alcohol consumption in adolescent nonhuman primates". Proceedings of the National Academy of Sciences. 107 (24): 11104–11109. doi: 10.1073/pnas.0912810107 . PMC   2890755 . PMID   20534463.
  21. ↑ Oscar-Berman M, Valmas MM, Sawyer KS, Ruiz SM, Luhar RB, Gravitz ZR (2014). "Profiles of impaired, spared, and recovered neuropsychologic processes in alcoholism". Alcohol and the Nervous System. Handbook of Clinical Neurology. Vol. 125. pp. 183–210. doi:10.1016/B978-0-444-62619-6.00012-4. ISBN   9780444626196. PMC   4515358 . PMID   25307576.{{cite book}}: |journal= ignored (help)
  22. ↑ Fein G, Torres J, Price LJ, Di Sclafani V (September 2006). "Cognitive performance in long-term abstinent alcoholic individuals". Alcohol. Clin. Exp. Res. 30 (9): 1538–44. doi:10.1111/j.1530-0277.2006.00185.x. PMC   1868685 . PMID   16930216.
  23. ↑ Bottlender M, Soyka M (2004). "Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment". Alcohol Alcohol. 39 (4): 357–61. doi: 10.1093/alcalc/agh073 . PMID   15208171.
  24. ↑ Moos RH, Moos BS (February 2006). "Rates and predictors of relapse after natural and treated remission from alcohol use disorders". Addiction. 101 (2): 212–22. doi:10.1111/j.1360-0443.2006.01310.x. PMC   1976118 . PMID   16445550.
  25. ↑ El-Sayed MS, Ali N, Ali ZE (1 March 2005). "Interaction Between Alcohol and Exercise". Sports Medicine. 35 (3): 257–269. doi:10.2165/00007256-200535030-00005. ISSN   1179-2035. PMID   15730339. S2CID   33487248.
  26. ↑ Krishnan HR, Sakharkar AJ, Teppen TL, Berkel TD, Pandey SC (2014). "The epigenetic landscape of alcoholism". Int. Rev. Neurobiol. International Review of Neurobiology. 115: 75–116. doi:10.1016/B978-0-12-801311-3.00003-2. ISBN   9780128013113. PMC   4337828 . PMID   25131543.
  27. ↑ Jangra A, Sriram CS, Pandey S, Choubey P, Rajput P, Saroha B, Bezbaruah BK, Lahkar M (October 2016). "Epigenetic Modifications, Alcoholic Brain and Potential Drug Targets". Ann Neurosci. 23 (4): 246–260. doi:10.1159/000449486. PMC   5075742 . PMID   27780992.
  28. ↑ Berkel TD, Pandey SC (April 2017). "Emerging Role of Epigenetic Mechanisms in Alcohol Addiction". Alcohol. Clin. Exp. Res. 41 (4): 666–680. doi:10.1111/acer.13338. PMC   5378655 . PMID   28111764.
  29. ↑ D'Addario C, Caputi FF, Ekström TJ, Di Benedetto M, Maccarrone M, Romualdi P, Candeletti S (February 2013). "Ethanol induces epigenetic modulation of prodynorphin and pronociceptin gene expression in the rat amygdala complex". J. Mol. Neurosci. 49 (2): 312–9. doi:10.1007/s12031-012-9829-y. PMID   22684622. S2CID   14013417.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.